Product
Liposomal aerosol cyclosporine
1 clinical trial
4 indications
Indication
Lung TransplantationIndication
Bronchiolitis ObliteransIndication
ImmunodeficiencyIndication
Chronic Lung Transplant RejectionClinical trial
A Pilot Study to Demonstrate Efficacy and Safety of Aerosol Liposomal Cyclosporine (L-CsA) in the Treatment of Bronchiolitis Obliterans Syndrome After Lung TransplantationStatus: Completed, Estimated PCD: 2015-08-01